Clinical preventive services: when is the juice worth the squeeze?
This paper provides an overview of clinical preventive services, including a definition of such services and the role of the U.S. Preventive Services Task Force in recommending which services should be routinely offered to patients. It also describes efforts to analyze the cost effectiveness of clinical preventive services and reviews the insurance coverage policies of private and public payers. Barriers to increased uptake of appropriate services are discussed, and policy-relevant issues are summarized.
Salinsky
Eileen
E
National Health Policy Forum, The George Washington University, Washington, D.C., USA.
D003256:Community Participation; D003362:Cost-Benefit Analysis; D019317:Evidence-Based Medicine / Q000191:economics; D006077:Government Agencies; D006264:Health Benefit Plans, Employee / Q000191:economics; D006291:Health Policy; D006801:Humans; D007342:Insurance Benefits; D019458:Insurance Coverage / Q000191:economics*; D017057:Medically Uninsured; D006278:Medicare / Q000191:economics; D011314:Preventive Health Services / Q000191:economics* / Q000706:statistics & numerical data; D014481:United States; D014611:Vaccination / Q000191:economics